Valuation: Ipsen

Market Cap 1.3TCr 1.48TCr 1.21TCr 1.11TCr 2.08TCr 1,42400Cr 2.11TCr 14TCr 5.6TCr 70TCr 5.55TCr 5.43TCr 2,42100Cr P/E 2026 *
14.4x
P/E 2027 * 14.1x
Enterprise Value 1.16TCr 1.33TCr 1.08TCr 993.54Cr 1.87TCr 1,27700Cr 1.9TCr 13TCr 5.02TCr 63TCr 4.98TCr 4.87TCr 2,17000Cr EV / Sales 2026 *
2.7x
EV / Sales 2027 * 2.35x
Free-Float
40.65%
Yield 2026 *
0.96%
Yield 2027 * 0.95%
1 day-2.82%
1 week-1.86%
Current month-6.16%
1 month-2.34%
3 months-2.82%
6 months+15.96%
Current year+33.11%
1 week 156
Extreme 156
164.5
1 month 155.8
Extreme 155.8
172.7
Current year 116
Extreme 116
173.5
1 year 101.9
Extreme 101.9
173.5
3 years 87.95
Extreme 87.95
173.5
5 years 77
Extreme 77
173.5
10 years 34.2
Extreme 34.2
173.5
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Date Insider Type Main position Quantity % Market Cap.
01/06/26 Fiscal year

Chief Executive Officer

-26,583 0.0317%
27/05/26 Sell

Chief Executive Officer

-1,000 0.0012%
25/02/26 Sell

Chairman

3,800 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
-2.82%-1.86%+41.68%+43.61% 1.48TCr
+0.86%+1.43%+47.17%+161.40% 1,06700Cr
+1.59%+4.09%+56.51%+52.79% 63TCr
+0.95%+1.91%+36.30%+83.13% 46TCr
+1.60%+6.25%+37.00%+30.00% 35TCr
-0.60%+1.52%+36.67%+39.80% 30TCr
-0.14%+0.60%+17.29%+18.19% 26TCr
+0.09%-2.82%-29.09%-41.29% 22TCr
+1.22%+2.66%+22.66%+59.81% 20TCr
-1.18%-3.70%+11.28%+67.43% 16TCr
Average +0.16%+1.01%+27.75%+51.49% 36.58TCr
Weighted average by Cap. +0.75%+1.94%+36.02%+78.01%

Financials

2026 *2027 *
Net sales 431.11Cr 490.84Cr 400.92Cr 367.89Cr 691.25Cr 47TCr 701.9Cr 4.76TCr 1.86TCr 23TCr 1.84TCr 1.8TCr 80TCr 452.74Cr 515.48Cr 421.04Cr 386.36Cr 725.94Cr 50TCr 737.13Cr 5TCr 1.95TCr 24TCr 1.94TCr 1.89TCr 84TCr
Net income 94Cr 106.97Cr 87Cr 80Cr 150.65Cr 10TCr 152.97Cr 1.04TCr 405.37Cr 5.06TCr 401.58Cr 392.93Cr 18TCr 95Cr 108.59Cr 89Cr 81Cr 152.93Cr 10TCr 155.28Cr 1.05TCr 411.49Cr 5.14TCr 407.65Cr 398.86Cr 18TCr
Net Debt -134.48Cr -153.11Cr -125.06Cr -114.76Cr -215.63Cr -15TCr -218.95Cr -1.49TCr -580.21Cr -7.25TCr -574.79Cr -562.4Cr -25TCr -234.66Cr -267.17Cr -218.23Cr -200.25Cr -376.26Cr -26TCr -382.06Cr -2.59TCr -1.01TCr -13TCr -1TCr -981.35Cr -44TCr
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
24/26/24 €158.40 -2.82% 95,940
23/26/23 €163.00 +0.43% 69,032
22/26/22 €162.30 +0.06% 71,244
21/26/21 €162.20 +0.12% 1,36,146
20/26/20 €162.00 +0.37% 1,05,156
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
158.40EUR
Average target price
161.67EUR
Spread / Average Target
+2.06%

Quarterly revenue - Rate of surprise